Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
30393821
DOI
10.1007/s12010-018-2899-8
PII: 10.1007/s12010-018-2899-8
Knihovny.cz E-zdroje
- Klíčová slova
- Diet-induced obese mice, Mass spectrometry, Metabolomics, Metformin, Plasma, Vildagliptin,
- MeSH
- diabetes mellitus 2. typu krev komplikace farmakoterapie metabolismus MeSH
- hmotnostní spektrometrie MeSH
- hypoglykemika aplikace a dávkování terapeutické užití MeSH
- kombinovaná farmakoterapie MeSH
- metabolomika * MeSH
- metformin aplikace a dávkování terapeutické užití MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- obezita krev komplikace metabolismus MeSH
- reprodukovatelnost výsledků MeSH
- vildagliptin aplikace a dávkování terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- hypoglykemika MeSH
- metformin MeSH
- vildagliptin MeSH
Type 2 diabetes mellitus (T2DM) is a major epidemiological problem. Metformin and vildagliptin are well-established antidiabetic drugs. The aim of the study was to evaluate the changes of plasma metabolic profile induced by a high-fat diet (HFD) and subsequent oral administration of metformin, vildagliptin, and their combination in a mouse model of diet-induced obesity (DIO)/T2DM analyzed using quadrupole-time-of-flight mass spectrometry (qTOF-MS). Metformin treatment increased the levels of butyrylcarnitine and acylcarnitine C18:1 concentrations and decreased the levels of isoleucine concentrations compared to untreated HFD mice. Vildagliptin treatment increased levels of butyrylcarnitine and acetylcarnitine. In summary, our metabolomics study revealed multiple differences between obese diabetic HFD mice and lean standard chow diet (SCD) mice, which were partially modifiable by subsequent metformin and vildagliptin treatment.
Faculty of Applied Sciences University of West Bohemia Univerzitní 8 306 14 Pilsen Czech Republic
Institute of Microbiology The Czech Academy of Sciences Vídeňská 1083 142 20 Prague 4 Czech Republic
Institute of Physiology The Czech Academy of Sciences Vídeňská 1083 142 20 Prague 4 Czech Republic
Citace poskytuje Crossref.org
